SCHEMBL28156782

SCHEMBL28156782

CN(CC(F)F)S(=O)(=O)c1ccc(NC(=O)c2ccccc2F)s1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.42
▸ MAPT P10636 3/20 0.42
▸ POLB P06746 2/20 0.42
▸ RAB9A P51151 6/20 0.40
▸ SMN1; SMN2 Q16637 5/20 0.40
▸ NPC1 O15118 5/20 0.40
▸ TP53 P04637 2/20 0.40
▸ NFKB1 P19838 1/20 0.40
▸ NFKB2 Q00653 1/20 0.40
▸ RELA Q04206 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.39
▸ HTT P42858 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ CASP3 P42574 1/20 0.39
▸ SENP7 Q9BQF6 1/20 0.39
▸ GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28156802 0.85 HDAC4 (0.54) LMNAMAPTPOLBRAB9ATP53
SCHEMBL28157364 0.84 LMNA (0.45) LMNAMAPTPOLBRAB9ASMN1; SMN2
SCHEMBL28156810 0.84 MAPT (0.42) LMNAMAPTPOLBRAB9ASMN1; SMN2
SCHEMBL28157366 0.83 MAPT (0.41) LMNAMAPTPOLBRAB9ASMN1; SMN2
SCHEMBL28157313 0.82 RXFP1 (0.46) LMNAMAPTPOLBTP53MEN1
SCHEMBL28846370 0.82 GSTO1 (0.42) LMNAMAPTPOLBRAB9ASMN1; SMN2
SCHEMBL16246257 0.81 CFTR (0.52) LMNAMAPTPOLBRAB9ASMN1; SMN2
SCHEMBL28156807 0.81 MEN1 (0.53) MAPTPOLBRAB9ANPC1TP53
SCHEMBL19494503 0.80 CFTR (0.39) LMNAMAPTPOLBRAB9ASMN1; SMN2
SCHEMBL28157321 0.79 TP53 (0.44) LMNAMAPTPOLBRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105531268-B Noval chemical compound and its pharmaceutical composition for treating cystic fibrosis 加拉佩格斯股份有限公司 2017-09-12 — — CN disclosed
Send feedback